School-age girls with fragile X syndrome show significantly poorer cognitive function and academic performance relative to age- and IQ-matched…
Articles by Patricia Inácio, PhD
Signs of hyperarousal, or overreactions to sensory stimuli, and abnormal processing of sensory information — including difficulty with eye gaze…
KGK Science, a wholly owned subsidiary of Wellbeing Digital Sciences, has entered into an agreement with Nova…
Tetra Therapeutics has announced the opening of its first site for a Phase 3 clinical trial assessing…
Tetra Therapeutics has launched three pivotal Phase 2b/3 studies to continue to assess the safety and effectiveness of…
Nova Mentis is teaming up with the University of Central Florida (UCF) Research Foundation to develop a new test that…
Zygel, an experimental cannabidiol gel developed by Zynerba Pharmaceuticals to ease abnormal behaviors in people with fragile X syndrome, was…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to NeuroNascent’s NNI-351 for the treatment of…
Healx has entered into an exclusive licensing agreement with Ovid Therapeutics to develop and commercialize gaboxadol in a potential combination…
Nova Mentis and Mycrodose Therapeutics have teamed up to test whether psychedelic treatments, such as Nova’s psilocybin —…